Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment

被引：0
|
作者：
Cea, Michele
Cagnetta, Antonia [1 ]
Cirmena, Gabriella
Garuti, Anna
Rocco, Ilaria
Palermo, Claudia
Pierri, Ivana [2 ]
Gobbi, Marco [3 ]
Ballestrero, Alberto [4 ]
Nencioni, Alessio
Patrone, Franco [4 ]
Carella, Angelo Michele [5 ]
机构：
[1] Univ Genoa, Dept Hematol, Genoa, Italy
[2] Univ Genoa, Chair Hematol, Genoa, Italy
[3] Univ Genoa, Chair Haematol, Genoa, Italy
[4] Univ Genoa, Chair Internal Med, Genoa, Italy
[5] Osped San Martino Genova, Genoa, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：521 / 521
页数：1
相关论文
共 50 条
  • [1] Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status
    Cea, Michele
    Cagnetta, Antonia
    Cirmena, Gabriella
    Garuti, Anna
    Rocco, Ilaria
    Palermo, Claudia
    Pierri, Ivana
    Reverberi, Daniele
    Nencioni, Alessio
    Ballestrero, Alberto
    Gobbi, Marco
    Carella, Angelo Michele
    Patrone, Franco
    LEUKEMIA & LYMPHOMA, 2013, 54 (02) : 342 - 352
  • [2] Glasdegib Hedgehog signaling inhibitor Treatment of myelodysplastic syndrome Treatment of chronic myelomonocytic leukemia Treatment of acute myeloid leukemia Treatment of myelofibrosis
    Gras, J.
    DRUGS OF THE FUTURE, 2017, 42 (05) : 265 - 274
  • [3] TREATMENT OF MOLECULAR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Semerad, L.
    Palackova, M.
    Jeziskova, I.
    Dvorakova, D.
    Razga, F.
    Bajerova, M.
    Prochazkova, J.
    Mayer, J.
    Racil, Z.
    HAEMATOLOGICA, 2013, 98 : 520 - 521
  • [4] Biomarker and gene profiling analyses in acute myeloid leukemia during treatment with Hedgehog signaling inhibitor
    Kakiuchi, Seiji
    Minami, Yosuke
    Fukushima, Nobuaki
    Kiyoi, Hitoshi
    Naoe, Tomoki
    Matsuoka, Hiroshi
    Minami, Hironobu
    ANNALS OF ONCOLOGY, 2015, 26 : 89 - 89
  • [5] Biomarker and Gene Profiling Analyses in Acute Myeloid Leukemia during Treatment with Hedgehog Signaling Inhibitor
    Kakiuchi, Seiji
    Minami, Yosuke
    Fukushima, Nobuaki
    Matsuoka, Hiroshi
    Naoe, Tomoki
    Minami, Hironobu
    BLOOD, 2015, 126 (23)
  • [6] Cortactin: A novel prognostic marker in chronic myeloid leukemia
    El-Razzaz, Mostafa
    Ahmed, Tamer
    Eissa, Deena
    Abdalla, Nourelhoda
    Shaheen, Mohammed
    Mohamed, Haydi
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2022, 47 (04): : 249 - 254
  • [7] Molecular relapse in PBSCT and BMT for chronic myeloid leukemia.
    Oehler, VG
    Guthrie, KA
    Gooley, T
    Beppu, LW
    Radich, JP
    BLOOD, 2002, 100 (11) : 548A - 549A
  • [8] Suppressing Hedgehog signaling reverses drug resistance of refractory acute myeloid leukemia
    Huang, Kaikai
    Sun, Zhiqiang
    Ding, Bingjie
    Jiang, Xuejie
    Wang, Zhixiang
    Zhu, Yufeng
    Meng, Fanyi
    ONCOTARGETS AND THERAPY, 2019, 12 : 7477 - 7488
  • [9] Chronic Myeloid Leukemia: Mechanisms of Resistance and Treatment
    Jabbour, Elias
    Parikh, Sameer A.
    Kantarjian, Hagop
    Cortes, Jorge
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (05) : 981 - +
  • [10] The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia
    Mohty, Mohamad
    Yong, Agnes S. M.
    Szydlo, Richard M.
    Apperley, Jane F.
    Melo, Junia V.
    BLOOD, 2007, 110 (01) : 380 - 383
12345